SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
DYGN - Dynagen
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
444 4 0 DYGND
Emcee:  Mark Strong Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
69 Maybe they went home early for the long week end? Maybe they want to announce Night Writer-5/23/1997
68 Well, it looks like Dynagen continues its unbroken string of failing to meet anDavid B. Higgs-5/22/1997
67 Dave, Thank you. You have been informative & make sense. LarryNight Writer-5/19/1997
66 Jim, Up 1/16 today, on double normal volume. Does anyone have any comment? SheSheldon C.-5/19/1997
65 Dave, The FDA requires 2 separate phase III trials. The second trial is tubrx-5/18/1997
64 Larry, I am not knowledgable in FDA clearance practicties as they seem to be vDavid B. Higgs-5/18/1997
63 David, Very informative post. I thought this was the final phase of phase IIINight Writer-5/17/1997
62 Sheldon, I didn't ask the good spin doctor about other products since I feDavid B. Higgs-5/17/1997
61 Dave, Great posting. Did they mention anything about any other products that tSheldon C.-5/17/1997
60 To all, I called Dynagen's PR firm early today to discuss Nic-Erase and GlDavid B. Higgs-5/16/1997
59 Jim, Thank you. It sounds like you know what you are talking about. Makes meNight Writer-5/15/1997
58 Dave, Bupropion (Zyban) has side effects in some patients. Seizures are rubrx-5/15/1997
57 David, Timing is everything. At least most of the time. After the Local anf NNight Writer-5/15/1997
56 Jim, I think the key point in your post is "marketing power". Since David B. Higgs-5/15/1997
55 David, This is actually a new name for an old drug. Zyban is the antideprubrx-5/15/1997
54 Glaxo Wellcome today announced FDA approval of a non-nicotine smoking cessationDavid B. Higgs-5/15/1997
53 Sheldon, I am an not a financial wize or TA person. I listen to those that arNight Writer-5/13/1997
52 Larry, What does CVUS do? they have a pretty wide spread between there high anSheldon C.-5/13/1997
51 Sheldon, The new kid on the block can post again. Mildly researched Superior PNight Writer-5/12/1997
50 Monday ............BummerDavid B. Higgs-5/12/1997
49 I don't think there is any way price would move up 13/32 four days after anDavid B. Higgs-5/9/1997
48 Mark, I copied this post from the Magainin (MAGN) thread, it addresses your qRichard Zangrillo-5/9/1997
47 Hi Mark, I agree that the results of Phase3 testing will be far more important.Sheldon C.-5/9/1997
46 Hello Larry, I don't know enough about the company they are in partnership Sheldon C.-5/9/1997
45 I think the _real_ good news will be the approval of the Nicotine-free "quMark Strong-5/9/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News